OneOncology, a national partnership of community oncologists, recently announced that Lee Schwartzberg, MD, FACP, a member of the George Clinical scientific leadership committee, has been named Chief Medical Officer (CMO).
According to OneOncology, the CMO position “provides a dynamic link between OneOncology and its physician partners, demonstrating the shared, foundational commitment to a physician-driven, data-driven, technology-powered, patient-centric organization.”
Schwartzberg has led oncology research for the science leadership committee of George Clinical since the acquisition of Vector Oncology in 2017. He brings the excellence he routinely pursues with OneOncology in the areas of innovation and scientific collaborations to the international George Clinical team ensuring our position at the forefront of oncologic medicine.
“I am thrilled to become the CMO for OneOncology because of the organization’s commitment to physician governance, leadership, and collaboration,” Dr. Schwartzberg said in the announcement. “The combined clinical and operational acumen of our practices leveraged at national scale empowers our doctors to provide the best care to the patients they serve.”
In addition to his George Clinical scientific leadership and CMO roles, Dr. Schwartzberg is a member of the OneOncology board of directors, the medical director of West Cancer Center and Research Institute, and a professor of medicine at The University of Tennessee Health Science Center.
Dr. Schwartzberg reflected, “I have always been interested in bringing innovation to the community oncology setting and I am looking forward to taking on this new challenge. My goal is to work in partnership with our physicians to provide the best care, experience, and outcomes for our patients.”
OneOncology is a national partnership of independent, community oncology practices driving the future of cancer care through a physician-led, data-driven, technology-powered, and patient-centric model improving the lives of everyone living with cancer.
